home · filing · 0001477932-25-002712
8-K
filed April 15, 2025, 7:59 PM ET
ticker ASPI
CIK 0001921865
other material
confidence high
sentiment neutral
materiality 0.75
ASP Isotopes plans spin-out of nuclear fuels unit QLE in 2H2025; adds Sipho Maseko to board
ASP Isotopes Inc.
Company intends to separate Quantum Leap Energy (QLE) as a standalone public company during 2H 2025 via spin-out.
Sipho Maseko, former Telkom CEO and Vodacom MD, appointed to ASPI board; receives 22,422 RSUs.
CTO Hendrik Strydom leaves ASPI board to join QLE board of managers, focusing on HALEU/Lithium-6 in South Africa.
Three new non-executive employees granted aggregate 250,000 restricted shares vesting over 4 years.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Sipho Maseko
Director
Effective 2025-04-14
Filed April 15, 2025, 7:59 PM ET
the Board appointed Sipho Maseko as director
Departed
Hendrik Strydom
Director
Effective 2025-04-14
Successor Sipho Maseko
Filed April 15, 2025, 7:59 PM ET
Dr. Hendrik Strydom, PhD, Chief Technology Officer of the Company, stepped down as a member of the board of directors of the Company
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Sipho Maseko was appointed as Director at ASP Isotopes Inc..
Action appointed
Role Director
Exact text from the filing
the Board appointed Sipho Maseko as director
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Hendrik Strydom departed as Director at ASP Isotopes Inc..
Action stepped down
Role Director
Exact text from the filing
Dr. Hendrik Strydom, PhD, Chief Technology Officer of the Company, stepped down as a member of the board of directors of the Company
View on SEC.gov
Source: SEC EDGAR
accession 0001477932-25-002712
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.